Accumulating evidence has suggested that the gap junction plays an important role in the determination of cerebral ischemia, but the underlying mechanisms remain to be elucidated. In this study, we assessed the effect of a gap-junction blocker, carbenoxolone (CBX), on ischemia/reperfusion-induced brain injury and the possible mechanisms. By using the transient cerebral ischemia model induced by occlusion of the middle cerebral artery for 30 min followed by reperfusion for 24 h, we found that pre-administration of CBX (25 mg/kg, intracerebroventricular injection, 30 min before cerebral ischemic surgery) diminished the infarction size in rats. And this was associated with a decrease of reactive oxygen species generation and inhibition of the activation of astrocytes and microglia. In PC12 cells, H 2 O 2 treatment induced more coupling and apoptosis, while CBX partly inhibited the opening of gap junctions and improved the cell viability. These results suggest that cerebral ischemia enhances the opening of gap junctions. Blocking the gap junction with CBX may attenuate the brain injury after cerebral ischemia/reperfusion by partially contributing to amelioration of the oxidative stress and apoptosis.
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INtrODUctION
Gap junctions exist ubiquitously in cell membranes as intercellular channels and are composed of transmembrane proteins called connexins (Cxs), which, when open, permit the intercellular diffusion of ions and small molecules [1, 2] . Gap junctions have numerous functions in the brain, such as the synchronization of electrical activity between neurons and the regulation of metabolic action between astrocytes [3, 4] . Cx43 hemichannels in astrocytes are susceptible to metabolic inhibition or in solutions free of divalent cations, which suggests that gap-junction communication is determined by the metabolic state [5, 6] . Gap junctions remain open after cerebral ischemia [7] , suggesting that gapjunction communication among astrocytes is involved in the pathological process after ischemic insult. The open gap junctions accelerate the spreading depression and induce cell death during ischemia or hypoxia [8] . On the other hand, however, communication through gap junctions is important in buffering ionic shifts and the exchange of metabolites generated during hypoxia or ischemia. Recent evidence suggests that this could be a protective strategy against hypoxic or ischemic insults [9] .
Recent studies have suggested that reducing gapjunction coupling with compounds results in decreased neuronal sensitivity to ischemic injury. However, many of the compounds used in vivo, such as octanol, heptanol and halothane, have major side-effects [10] [11] [12] , and intefere with synaptic transmission [13, 14] . Most of their neuroprotective effects in cerebral ischemia depend not only on blocking gap junctions, but also other actions. In this study, we attempted to explore whether specific gap-junction blockers affect the cellular sensitivity to ischemic injury in rats and whether such blockade diminishes the diffusion of reactive oxygen species (ROS) in vitro. Carbenoxolone (CBX) is effective in blocking gap-junction coupling [15] , interferes little with synaptic function in vivo and in vitro [16] [17] [18] [19] , and induces minimal changes in intrinsic neuronal characteristics [20, 21] .
In addition, this agent has been widely used as a mineralocorticoid agonist to inhibit 11-beta hydroxysteroid dehydrogenase and block gap-junction communication in various experimental studies [15, 22, 23] .
Currently, the effect of CBX on ischemic damage remains to be elucidated [24, 25] . Perez et al. reported that pretreatment with CBX, via a cannula implanted into the hippocampus in one hemisphere, results in decreased apoptosis in a global model of transient ischemia in rats [26] .
Another study suggested that blocking gap-junctional communication with CBX or downregulating Cx43 increases the survival of pyramidal neurons in the ipsilateral hippocampus and improves behavioral scores in the rodent model of middle cerebral artery occlusion (MCAO) [27] .
However, Tamura et al. reported that CBX accelerates the initiation and propagation of cortical spreading depression and worsens the outcome of focal cerebral ischemia [28] .
Furthermore, some evidence has shown that CBX cannot pass the blood-brain-barrier very efficiently [29, 30] .
Therefore, the current study was performed to investigate 
MAtErIAL AND MEtHODs
Animals
Adult male Sprague-Dawley rats weighing 270-300 g from the Animal Center of Lanzhou University were used. 
cerebral Ischemia
MCAO was established by the intraluminal filament method as described previously [31] . Briefly, animals were anesthetized by 10% chloral hydrate (360 mg/kg, i. p.) and the right common and external carotid arteries were 
carbenoxolone Administration
The MCAO rats were randomly divided into two groups (12 rats each group). The CBX group received 
Measurement of rOs
Four rats from each group were randomly selected for ROS measurement. The ipsilateral striatum was dissected out and minced on ice, incubated with 0.25% trypsin at 37°C for (1:400, 2 h at 37°C) followed by streptavidin-peroxidase
(1:400, 1 h at 37°C). The same treatment omitting the primary antibodies served as a negative control.
cell counts
Total cell numbers were counted in a double-blinded manner. In these experiments, CD11b-and GFAP-positive cells were counted under a 20× objective in the ipsilateral striatum from three sections (at 0.12, 1.12, and 2.12 mm from bregma) from each rat, in four randomly-selected nonoverlapping areas (119 × 93 μm 2 ) in each section.
cell culture PC12 cells were cultured in DMEM containing 10% fetal bovine serum and antibiotics (penicillin, 100 IU/mL; streptomycin, 100 μg/mL). The cultures were maintained at 37°C in 95% air-5% CO 2 in a humidified incubator.
Cell viability was evaluated with the MTT assay using a microplate reader (Bio-Rad Laboratory, Hercules, CA).
H 2 O 2 treatment
The culture medium was removed and PC12 cells were 
scrape-Loading
Gap-junction permeability was determined using the Lucifer Yellow (LY) scrape-loading technique [32] . Confluent cells 
Western blot
Four rats were selected randomly from each group, anesthetized with pentobarbital, and the ipsilateral striatum was collected on ice. Samples were frozen in liquid nitrogen, homogenized, and total protein was extracted using RIPA buffer containing protease inhibitors. Harvested 
statistical Analysis
All data are expressed as mean ± SEM. Differences between groups were analyzed by one-way ANOVA. For the influence of CBX on the infarct size relative to wholebrain volume (%), the Mann-Whitney U test was used for each evaluation. For other data, unpaired Student's t test was used. P <0.05 was considered statistically significant.
rEsULts cbX Pre-treatment reduced Infarct size Following McAO
To evaluate the effect of CBX on brain damage after cerebral ischemia, we measured the infarct size by cresyl violet staining. CBX treatment significantly reduced the infarct size compared with untreated rats (Fig. 1A, B) .
cbX Pre-treatment reduced cx43 Expression and rOs Production after cerebral Ischemia
To examine the changes of gap junctions after cerebral ischemia, we determined the Cx43 expression in the ipsilateral striatum. Immunohistochemistry showed that
Cx43 expression was higher in the ipsilateral striatum of ischemic rats than that in control rats. CBX treatment markedly decreased Cx43 expression in ischemic rats ( Fig.   2A ). We also quantified the Cx43 level in the ipsilateral striatum using Western blot and found similar results (Fig. 2B, C) . Because cerebral ischemia can cause the accumulation of ROS, we measured the DCF fluorescence in the ipsilateral striatum and found that it was higher after cerebral ischemia, and the production of ROS was attenuated by CBX pre-treatment (Fig. 2D) . 
cbX treatment Inhibited the Activation of Glial cells after cerebral Ischemia Previous studies indicated that
Cx43 is mainly localized in glia, and ischemia usually causes the activation of astrocytes and microglia, so whether blocking gap junctions affects glial activity after cerebral ischemia is of interest. Immunohistochemistry showed that the number of GFAP-positive astrocytes induced by ischemia in the ipsilateral striatum was decreased by CBX treatment (Fig. 3A, B) . Likewise, CBXtreated rats had fewer CD-11b-positive microglia than the untreated rats after ischemia (Fig. 3C, D) . 4A, B) . The cell survival was also improved by treatment with CBX under H 2 O 2 stress (Fig. 4C) .
cbX Inhibited the Gap Junction coupling and Improved
cbX suppressed cx43 Expression in Pc12 cells after H 2 O 2 treatment
Recent studies have shown that Cx43 is distributed in PC12 cells after induction [33] . To address whether CBX In addition, after PC12 cells were incubated with H 2 O 2 and CBX together, the apoptosis ratio was clearly decreased (Fig. 6A, B) .
DIscUssION
So far, many studies have documented the roles of gap junctions in cerebral ischemia. But argument continues, partly due to different experimental models, leading to different and even opposing results and conclusions [34] [35] [36] .
In vivo, most of the studies were designed to down-or up-regulate specific connexins, then investigate the gapjunction effects and underlying mechanisms in cerebral ischemia. But they failed to link the connexin expression to the actual level of opening of gap junctions [37] . In vitro, studies cannot duplicate the ischemic condition, although quantitative assays were performed to evaluate the extent of gap-junction coupling [38] . In the present study, we found that ischemia-induced overexpression of Cx43 was accompanied by ROS accumulation and glial activation. However, the roles of Cx43 in the ischemic process remain controversial. Cx43 heterozygous-null mice and mice with astrocytic Cx43 removed by cre expression are more susceptible to infarct expansion after focal ischemia [37, 39, 40] .
Alternatively, when hypoxic-ischemic brain injury induces an acute inflammatory reaction and reactive astrogliosis associated with peri-lesional upregulation of Cx43, human umbilical cord blood cell transplantation accelerates the regression of inflammatory events, narrows the perilesional astrocytic wall, and leads to the downregulation of Cx43 expression [41] . A mimetic peptide that blocks Cx43 hemichannels after perfusion into the lateral ventricle reduces seizure activity and improves the survival of oligodendrocytes and neurons after ischemia in sheep [42] .
In vitro, the gap-junction coupling induced by H 2 O 2 treatment was partly counteracted by CBX treatment. (Fig. 5A, B) . with the production and accumulation of ROS. And ROS stress enhances the secondary brain injury after cerebral ischemia [43] [44] [45] . Inhibition of gap junctions with CBX decreases the diffusion of ROS, limiting the secondary injury factors in the ischemic core, and protecting cells in the penumbra to attenuate the expansion of the infarct [46, 47] .
Other studies also indicate that CBX acts partially as an antioxidant [26] .
Not only do ROS accumulate, but activation of glial cells also occurs after cerebral ischemia. The roles of activated glial cells in brain injury remain controversial; presumably, they have advantages and disadvantages.
Glia may play complex roles in the development of neuropathology, for example in triggering secondary injury or promoting self-repair by secreting cytokines [48] [49] [50] . Here, we found that CBX reduced the activation of microglia and astroglia localized in the penumbra after transient cerebral ischemia. However, the underlying mechanisms remain to be clarified. Most evidence indicates that Cx43
is localized in the cell membranes of activated astrocytes and microglia [51, 52] . Accumulation and diffusion of ROS may activate microglia and astrocytes, and these effects may be amplified by gap-junction communication [53] . In addition, apoptosis signals can diffuse through gap junctions [54] .
Previous studies showed that CBX treatment decreases the numbers of TUNEL-positive neurons in global ischemia [26] and its administration to ischemic pups prevents caspase-3 activation [55] . In our experiment, H 2 O 2 treatment induced apoptosis in PC12 cells accompanied by gap-junction coupling. And after blocking the gap junctions with CBX, the apoptosis ratio was attenuated under ROS stress.
These results confirmed that gap junctions are involved in apoptosis progression in brain injury. 
